Will Boston Scientific (BSX) Beat Estimates Again in Its Next Earnings Report?

Boston Scientific (BSX) is positioned for another earnings beat in its upcoming July 23, 2025, report, driven by a strong historical record of exceeding estimates. The medical device firm has averaged a 9.82% earnings surprise over the past two quarters, including an 11.94% beat last quarter. This positive momentum is reinforced by a current Zacks Earnings ESP of +0.88% and a Zacks Rank #2 (Buy), collectively indicating a high probability of surpassing consensus forecasts.

Analysis

Boston Scientific (BSX) presents a compelling case for an upcoming earnings beat, supported by both historical performance and forward-looking quantitative metrics. The medical device manufacturer has established a strong track record, surpassing earnings estimates by an average of 9.82% over the past two quarters, with the most recent report delivering an 11.94% surprise on earnings of $0.75 per share versus a $0.67 consensus. This positive momentum is reinforced by a Zacks Rank of #2 (Buy) and a positive Earnings ESP (Expected Surprise Prediction) of +0.88%, which indicates that the most recent analyst estimates are trending higher. The combination of a positive ESP and a strong Zacks Rank has historically correlated with a positive earnings surprise approximately 70% of the time, suggesting a high probability that BSX will outperform expectations in its next report on July 23, 2025.

Key Decisions for Investors

• Given the high statistical probability of an earnings beat based on the positive ESP and #2 Buy rank, investors may consider holding or increasing their long positions in BSX leading into the July 23, 2025 earnings announcement.
• Traders could evaluate options strategies to capitalize on potential pre-earnings volatility and a likely upward price movement should the company deliver another strong earnings surprise.
• It is crucial to monitor for any last-minute revisions to analyst estimates or the Zacks Rank, as these metrics are the primary drivers of the bullish outlook and any negative change could undermine the thesis.